Mind Medicine (MindMed) Inc.
MMED
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -16.16% | 0.41% | -9.62% | -31.89% | 27.06% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.83% | 46.19% | 14.69% | -16.19% | 6.43% |
| Operating Income | -44.83% | -46.19% | -14.69% | 16.19% | -6.43% |
| Income Before Tax | 57.08% | -45.58% | 23.65% | 79.90% | -119.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 57.08% | -45.58% | 23.65% | 79.90% | -119.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 57.08% | -45.58% | 23.65% | 79.90% | -119.22% |
| EBIT | -44.83% | -46.19% | -14.69% | 16.19% | -6.43% |
| EBITDA | -48.32% | -- | -- | -- | -- |
| EPS Basic | 75.85% | 30.21% | 61.08% | 89.22% | -74.41% |
| Normalized Basic EPS | 75.86% | 30.21% | 61.06% | 84.53% | -74.42% |
| EPS Diluted | 69.44% | 30.30% | 39.12% | 66.28% | -74.93% |
| Normalized Diluted EPS | 76.41% | 30.21% | 62.20% | 85.23% | -74.42% |
| Average Basic Shares Outstanding | 77.74% | 108.61% | 96.15% | 86.42% | 25.69% |
| Average Diluted Shares Outstanding | 81.97% | 108.61% | 102.01% | 95.21% | 25.69% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |